世界の内視鏡的逆行性胆管膵管造影(ERCP)市場2019年-2027年:製品種類別(内視鏡、内治療装置、画像システム、エネルギー装置、その他)、用途別、エンドユーザー別

■ 英語タイトル:Endoscopic Retrograde Cholangiopancreatography Market by Product Type (Endoscopes, Endotherapy Devices, Imaging Systems, Energy Devices, And Others), Application (Biliary Sphincterotomy, Biliary Dilatation, Biliary Stenting, Pancreatic Sphincterotomy, Pancreatic Duct Dilatation, And Pancreatic Duct Stenting), and End User (Hospitals & Clinics, Ambulatory Surgery Centers, And Others): Global Opportunity Analysis and Industry Forecast, 2019-2027

調査会社Allied Market Research社が発行したリサーチレポート(データ管理コード:ALD21JU048)■ 発行会社/調査会社:Allied Market Research
■ 商品コード:ALD21JU048
■ 発行日:2021年4月
■ 調査対象地域:グローバル
■ 産業分野:医療機器
■ ページ数:265
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single UserUSD6,168 ⇒換算¥912,864見積依頼/購入/質問フォーム
5 UserUSD6,929 ⇒換算¥1,025,492見積依頼/購入/質問フォーム
Enterprise UserUSD9,663 ⇒換算¥1,430,124見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界の内視鏡的逆行性胆管膵管造影(ERCP)市場2019年-2027年:製品種類別(内視鏡、内治療装置、画像システム、エネルギー装置、その他)、用途別、エンドユーザー別]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Allied Market Research社の本調査レポートは、世界の内視鏡的逆行性胆管膵管造影(ERCP)市場について調査し、イントロダクション、エグゼクティブサマリー、市場概要、製品種類別(内視鏡、エンドセラピー装置、画像装置、エネルギー装置、その他)分析、用途別(胆管括約筋切開術、胆道拡張、胆管ステント留置、膵臓括約筋切開術、膵管拡張)分析、エンドユーザー別(病院・クリニック、外来手術センター、その他)分析、地域別分析、企業情報などを整理しました。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の内視鏡的逆行性胆管膵管造影(ERCP)市場規模:製品種類別(内視鏡、エンドセラピー装置、画像装置、エネルギー装置、その他)
・世界の内視鏡的逆行性胆管膵管造影(ERCP)市場規模:用途別(胆管括約筋切開術、胆道拡張、胆管ステント留置、膵臓括約筋切開術、膵管拡張)
・世界の内視鏡的逆行性胆管膵管造影(ERCP)市場規模:エンドユーザー別(病院・クリニック、外来手術センター、その他)
・世界の内視鏡的逆行性胆管膵管造影(ERCP)市場規模:地域別
・企業情報

The global endoscopic retrograde cholangiopancreatography market was valued at $1,212.94 million in 2019, and is projected to reach $1,876.75 million by 2027, registering a CAGR of 5.6% from 2019 to 2027.

Endoscopic retrograde cholangiopancreatography (ERCP) is a procedure used to diagnose diseases of the gallbladder, biliary system, pancreas, and liver. ERCP devices use a combination of fluoroscopic imaging and luminal endoscopy for the diagnosis and treatment of pancreatobiliary system related disorders. By product type, the endoscopic retrograde cholangiopancreatography market is categorized into endoscopes, endotherapy devices, imaging systems, energy devices, and others. Endotherapy devices are majorly used for the treatment of various medical conditions such as Barrett’s disease., biliary disease, colitis, Crohn’s disease, gastroesophageal reflux disorder (GERD), liver disease, pancreatitis, inflammatory bowel disease, and peptic ulcer disease. The endotherapy devices segment is further categorized into sphincterotome, guidewire, balloon, basket, lithotripters, stent, grasping forceps, cannula, and single use balloon dilator.

The growth of the global endoscopic retrograde cholangiopancreatography (ERCP) market is majorly driven by rise in incidences of gastrointestinal and chronic biliary disorders such as Barrett’s disease, biliary disease, colitis, Crohn’s disease, gastroesophageal reflux disorder (GERD), liver disease, pancreatitis, inflammatory bowel disease, and peptic ulcer disease. Further, rapid increase in frequencies of benign tumors of the liver and pancreas coupled with surge in aging population and rise in awareness related to devices used in ERCP for the treatment of disorders drive the market growth. However, high costs associated with treatment from ERCP and side-effects of the procedure such as post-ERCP pancreatitis are expected to hamper the growth of the market. On the contrary, emerging countries possess high growth potential, owing to improvement of healthcare infrastructures in these countries.

The endoscopic retrograde cholangiopancreatography market is segmented into product type, application, end user, and region. On the basis of product type, into endoscopes, endotherapy devices, imaging systems, energy devices, and others. Further, the endotherapy devices segment is divided into sphincterotome, lithotripter, stents, cannulas, forceps, snares, catheters, guiding wires, balloons, baskets, and others. By application, it is divided into biliary sphincterotomy, biliary dilatation, biliary stenting, pancreatic sphincterotomy, pancreatic duct dilatation, and pancreatic duct stenting. By end user, it is segregated into hospitals & clinics, ambulatory surgery centers, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the key players operating in the endoscopic retrograde cholangiopancreatography market include Olympus Corporation, Conmed Corporation, Hobbs Medical, Inc., TeleMed Systems, Inc., Boston Scientific Corporation, Cook Group Incorporation, Ambu, Inc., Becton, Dickinson and Company, Fujifilm Holding Corporation, and Medtronic Plc.

KEY BENEFITS FOR STAKEHOLDERS
 This report entails a detailed quantitative analysis along with the current global endoscopic retrograde cholangiopancreatography market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessment.
 The endoscopic retrograde cholangiopancreatography market forecast is studied from 2019 to 2027.
 The market size and estimations are based on a comprehensive analysis of key developments in the industry.
 A qualitative analysis based on innovative products facilitates strategic business planning.
 The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

KEY MARKET SEGMENTS
By Product Type
• Endoscopes
• Endotherapy Devices
o Sphincterotome
o Lithotripter
o Stents
o Cannulas
o Forceps
o Snares
o Catheters
o Guiding Wires
o Balloons
o Baskets
o Others
• Imaging Devices
• Energy Devices
• Others

By Application
• Biliary Sphincterotomy
• Biliary Dilatation
• Biliary Stenting
• Pancreatic Sphincterotomy
• Pancreatic Duct Dilatation
• Pancreatic Duct Stenting

By End User
• Hospitals & Clinics
• Ambulatory Surgery Centers
• Others

By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o South Africa
o Saudi Arabia
o Rest of LAMEA

KEY MARKET PLAYERS
• Olympus Corporation,
• Conmed Corporation,
• Hobbs Medical, Inc.
• TeleMed Systems, Inc.
• Boston Scientific Corporation
• Cook Group incorporation
• Fujifilm holdings Corporation
• Becton, Dickinson and Company
• Medtronic, Plc.
• Ambu Inc.

List of other players in the value chain (profiles not included in the report):
• Jiangsu ATE Medical Technology Co, Ltd.
• Johnson & Johnson Services
• Changzhou Health Microport Medical Device Co, Ltd.
• Merit Medical System, Inc.
• Karl Storz

*** レポート目次(コンテンツ)***

CHAPTER 1:INTRODUCTION

1.1.Report description

1.1.1.Key benefits for stakeholders
1.1.2.Key market segments

1.2.Research methodology

1.2.1.Secondary research
1.2.2.Primary research
1.2.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Top player positioning, 2019
3.4.Porter’s five forces analysis
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Rise in incidences of gastrointestinal and chronic biliary disorders
3.5.1.2.Increase in frequencies of benign tumors of the liver and pancreas
3.5.1.3.Increase in ageing population

3.5.2.Restraints

3.5.2.1.High costs associated with treatment from ERCP devices
3.5.2.2.Side-effects of the procedure such as post-ERCP pancreatitis

3.5.3.Opportunity

3.5.3.1.Rise in awareness

3.6.Impact analysis of COVID-19 on market

CHAPTER 4:ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Endoscopes

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Endotherapy Devices

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by type

4.3.2.1.Sphincterotome

4.3.2.1.1.Market size and forecast

4.3.2.2.Lithotripter

4.3.2.2.1.Market size and forecast

4.3.2.3.Stents

4.3.2.3.1.Market size and forecast

4.3.2.4.Cannula

4.3.2.4.1.Market size and forecast

4.3.2.5.Forceps

4.3.2.5.1.Market size and forecast

4.3.2.6.Snare

4.3.2.6.1.Market size and forecast

4.3.2.7.Catheter

4.3.2.7.1.Market size and forecast

4.3.2.8.Guiding wires

4.3.2.8.1.Market size and forecast

4.3.2.9.Balloons

4.3.2.9.1.Market size and forecast

4.3.2.10.Basket

4.3.2.10.1.Market size and forecast

4.3.2.11.Others

4.3.2.11.1.Market size and forecast

4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country

4.4.Imaging Devices

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

4.5.Energy Devices

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country

4.6.Others

4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country

CHAPTER 5:ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Biliary Sphincterotomy

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Biliary Dilatation

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Biliary Stenting

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.5.Pancreatic Sphincterotomy

5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country

5.6.Pancreatic Duct Dilatation

5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country

5.7.Pancreatic Duct Stenting

5.7.1.Market size and forecast, by region
5.7.2.Market analysis, by country

CHAPTER 6:ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospitals & Clinics

6.2.1.Market size and forecast
6.2.2.Market analysis, by country

6.3.Ambulatory surgery centers

6.3.1.Market size and forecast
6.3.2.Market analysis, by country

6.4.Others

6.4.1.Market size and forecast
6.4.2.Market analysis, by country

CHAPTER 7:ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America endoscopy device market, by country

7.2.2.1.U.S. Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.2.2.2.U.S. Endoscopic Retrograde Cholangiopancreatography Market, by application
7.2.2.3.U.S. Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.2.2.4.Canada Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.2.2.5.Canada Endoscopic Retrograde Cholangiopancreatography Market, by application
7.2.2.6.Canada Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.2.2.7.Mexico Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.2.2.8.Mexico Endoscopic Retrograde Cholangiopancreatography Market, by application
7.2.2.9.Mexico Endoscopic Retrograde Cholangiopancreatography Market, by end user

7.2.3.North America Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.2.4.North America Endoscopic Retrograde Cholangiopancreatography Market, by application
7.2.5.North America Endoscopic Retrograde Cholangiopancreatography Market, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe Endoscopic Retrograde Cholangiopancreatography Market, by country

7.3.2.1.Germany Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.2.2.Germany Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.2.3.Germany Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.3.2.4.France Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.2.5.France Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.2.6.France Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.3.2.7.UK Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.2.8.UK Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.2.9.UK Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.3.2.10.Italy Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.2.12.Italy Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.2.13.Italy Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.3.2.14.Spain Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.2.15.Spain Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.2.16.Spain Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.3.2.17.Rest of Europe Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.2.18.Rest of Europe Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.2.19.Rest of Europe Endoscopic Retrograde Cholangiopancreatography Market, by end user

7.3.3.Europe Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.4.Europe Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.5.Europe Endoscopic Retrograde Cholangiopancreatography Market, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by country

7.4.2.1.Japan Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.2.2.Japan Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.2.3.Japan Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.4.2.4.China Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.2.5.China Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.2.6.China Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.4.2.7.Australia Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.2.8.Australia Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.2.9.Australia Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.4.2.10.India Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.2.11.India Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.2.12.India Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.4.2.13.South Korea Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.2.14.South Korea Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.2.15.South Korea Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.4.2.16.Rest of Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.2.17.Rest of Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.2.18.Rest of Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by end user

7.4.3.Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.4.Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.5.Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by country
7.5.2.1.Brazil Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.5.2.2.Brazil Endoscopic Retrograde Cholangiopancreatography Market, by application
7.5.2.3.Brazil Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.5.2.4.Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.5.2.5.Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Market, by application
7.5.2.6.Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.5.2.7.South Africa Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.5.2.8.South Africa Endoscopic Retrograde Cholangiopancreatography Market, by application
7.5.2.9.South Africa Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.5.2.10.Rest of LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.5.2.11.Rest of LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by application
7.5.2.12.Rest of LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by end user

7.5.3.LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.5.4.LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by application
7.5.5.LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by end user

CHAPTER 8:COMPANY PROFILES

8.1.AMBU INC.

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments

8.2.BECTON, DICKINSON AND COMPANY

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance

8.3.BOSTON SCIENTIFIC CORPORATION.

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments

8.4.CONMED CORPORATION.

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance

8.5.COOK GROUP INCORPORATION

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio

8.6.HOBBS MEDICAL, INC.

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio

8.7.FUJIFILM HOLDINGS CORPORATION.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance

8.8.MEDTRONIC PLC.

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance

8.9.OLYMPUS CORPORATION

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments

8.10.TELEMED SYSTEM, INC.

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio

LIST OF TABLES

TABLE 01.GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE 2019–2027 ($MILLION)
TABLE 02.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR ENDOSCOPES, BY REGION, 2019-2027 ($MILLION)
TABLE 03.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR ENDOTHERAPY DEVICES, BY TYPE, 2019-2027 ($MILLION)
TABLE 04.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR ENDOTHERAPY DEVICES, BY REGION, 2019-2027 ($MILLION)
TABLE 05.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR IMAGING DEVICES, BY REGION, 2019-2027 ($MILLION)
TABLE 06.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR ENERGY DEVICES, BY REGION, 2019-2027 ($MILLION)
TABLE 07.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR OTHERS, BY REGION, 2019-2027 ($MILLION)
TABLE 08.GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 09.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR BILIARY SPHINCTEROTOMY, BY REGION, 2019-2027 ($MILLION)
TABLE 10.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR BILIARY DILATATION, BY REGION, 2019-2027 ($MILLION)
TABLE 11.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR BILIARY STENTING BY REGION, 2019-2027 ($MILLION)
TABLE 12.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR PANCREATIC SPHINCTEROTOMY BY REGION, 2019-2027 ($MILLION)
TABLE 13.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR PANCREATIC DUCT DILATATION, BY REGION, 2019-2027 ($MILLION)
TABLE 14.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR PANCREATIC DUCT STENTING, BY REGION, 2019-2027 ($MILLION)
TABLE 15.GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 16.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019-2027 ($MILLION)
TABLE 17.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2019–2027 ($MILLION)
TABLE 18.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 19.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 20.NORTH AMERICA ENDOSCOPY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 21.U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 22.U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 23.U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 24.CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 25.CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 26.CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 27.MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 28.MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 29.MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 30.NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 31.NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 32.NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 33.EUROPE ENDOSCOPY DEVICEMARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 34.GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 35.GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 36.GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 37.FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 38.FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 39.FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 40.UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 41.UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 42.UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 43.ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 44.ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 45.ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 46.SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 47.SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 48.SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 49.REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 50.REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 51.REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 52.EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 53.EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 54.EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 55.ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 56.JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 57.JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 58.JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 59.CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 60.CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 61.CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 62.AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 63.AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 64.AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 65.INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 66.INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 67.INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 68.SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 69.SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 70.SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 71.REST OF ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 72.REST OF ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 73.REST OF ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 74.ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 75.ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 76.ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 77.LAMEA ENDOSCOPY DEVICEMARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 78.BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 79.BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 80.BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 81.SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 82.SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 83.SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 84.SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 85.SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 86.SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 87.REST OF LAMEA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 88.REST OF LAMEA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 89.REST OF LAMEA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 90.LAMEA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 91.LAMEA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 92.LAMEA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 93.AMBU: COMPANY SNAPSHOT
TABLE 94.AMBU: OPERATING SEGMENTS
TABLE 95.AMBU: PRODUCT PORTFOLIO
TABLE 96.BD: COMPANY SNAPSHOT
TABLE 97.BD: OPERATING SEGMENTS
TABLE 98.BD: PRODUCT PORTFOLIO
TABLE 99.BOSTON: COMPANY SNAPSHOT
TABLE 100.BOSTON: OPERATING SEGMENTS
TABLE 101.BOSTON: PRODUCT PORTFOLIO
TABLE 102.CONMED COMPANY SNAPSHOT
TABLE 103.CONMED: OPERATING SEGMENTS
TABLE 104.CONMED: PRODUCT PORTFOLIO
TABLE 105.COOK: COMPANY SNAPSHOT
TABLE 106.COOK: OPERATING SEGMENTS
TABLE 107.COOK: PRODUCT PORTFOLIO
TABLE 108.HOBBS MEDICAL: COMPANY SNAPSHOT
TABLE 109.HOBBS MEDICAL: OPERATING SEGMENTS
TABLE 110.HOBBS MEDICAL: PRODUCT PORTFOLIO
TABLE 111.FUJIFILM: COMPANY SNAPSHOT
TABLE 112.FUJIFILM: OPERATING SEGMENTS
TABLE 113.FUJIFILM: PRODUCT PORTFOLIO
TABLE 114.MEDTRONIC: COMPANY SNAPSHOT
TABLE 115.MEDTRONIC: OPERATING SEGMENTS
TABLE 116.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 117.OLYMPUS: COMPANY SNAPSHOT
TABLE 118.OLYMPUS: OPERATING SEGMENTS
TABLE 119.OLYMPUS: PRODUCT PORTFOLIO
TABLE 120.TELMED: COMPANY SNAPSHOT
TABLE 121.TELEMED: OPERATING SEGMENTS
TABLE 122.TELEMED: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS IN THE GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET
FIGURE 03.TOP PLAYER POSITIONING, 2019
FIGURE 04.MODERATE BARGAINING POWER OF BUYERS
FIGURE 05.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06.LOW THREAT OF NEW ENTRANTS
FIGURE 07.LOW THREAT OF SUBSTITUTION
FIGURE 08.HIGH COMPETITIVE RIVALRY
FIGURE 09.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR ENDOSCOPES BY COUNTRY, 2019–2027 (%)
FIGURE 10.ERCP MARKET FOR ENDOTHERAPY DEVICES BY SPHINCTEROTOME, 2019-2027
FIGURE 11.ERCP MARKET FOR ENDOTHERAPY DEVICES BY LITHOTRIPTER, 2019-2027
FIGURE 12.ERCP MARKET FOR ENDOTHERAPY DEVICES BY STENTS, 2019-2027
FIGURE 13.ERCP MARKET FOR ENDOTHERAPY DEVICES BY CANNULA, 2019-2027
FIGURE 14.ERCP MARKET FOR ENDOTHERAPY DEVICES BY FORCEPS, 2019-2027
FIGURE 15.ERCP MARKET FOR ENDOTHERAPY DEVICES BY SNARE, 2019-2027
FIGURE 16.ERCP MARKET FOR ENDOTHERAPY DEVICES BY CATHETER, 2019-2027
FIGURE 17.ERCP MARKET FOR ENDOTHERAPY DEVICES BY GUIDING WIRES, 2019-2027
FIGURE 18.ERCP MARKET FOR ENDOTHERAPY DEVICES BY BALLOON, 2019-2027
FIGURE 19.ERCP MARKET FOR ENDOTHERAPY DEVICES BY BASKET, 2019-2027
FIGURE 20.ERCP MARKET FOR ENDOTHERAPY DEVICES BY OTHERS, 2019-2027
FIGURE 21.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR ENDOTHERAPY DEVICES, BY COUNTRY, 2019–2027 (%)
FIGURE 22.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR IMAGING DEVICES, BY COUNTRY, 2019–2027 (%)
FIGURE 23.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR ENERGY DEVICES BY COUNTRY, 2019–2027 (%)
FIGURE 24.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR OTHERS BY COUNTRY, 2019–2027 (%)
FIGURE 25.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR BILIARY SPHINCTEROTOMY, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 26.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR BILIARY DILATATION, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 27.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR BILIARY STENTING, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 28.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR PANCREATIC SPHINCTEROTOMY, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 29.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR PANCREATIC DUCT DILATATION, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 30.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR PANCREATIC DUCT STENTING, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 31.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 32.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 33.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR OTHERS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 34.AMBU: NET SALES, 2018-2020 ($MILLION)
FIGURE 35.AMBU REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 36.AMBU: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 37.BD: NET SALES, 2018-2020 ($MILLION)
FIGURE 38.BD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 39.BD: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 40.BOSTON: NET SALES, 2018-2020 ($MILLION)
FIGURE 41.BOSTON: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 42.BOSTON: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 43.CONMED: NET SALES, 2018-2020 ($MILLION)
FIGURE 44.CONMED: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 45.CONMED: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 46.FUJIFILM: NET SALES, 2018–2020 ($MILLION)
FIGURE 47.FUJIFILM: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 48.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 49.MEDTRONIC: REVENUE SHARE BY SEGMENTS, 2020 (%)
FIGURE 50.MEDTRONIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 51.OLYMPUS: NET SALES, 2018–2020 ($MILLION)
FIGURE 52.OLYMPUS: REVENUE SHARE BY SEGMENTS, 2020(%)
FIGURE 53.OLYMPUS: REVENUE SHARE BY REGION, 2020 (%)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(ALD21JU048 )"世界の内視鏡的逆行性胆管膵管造影(ERCP)市場2019年-2027年:製品種類別(内視鏡、内治療装置、画像システム、エネルギー装置、その他)、用途別、エンドユーザー別" (英文:Endoscopic Retrograde Cholangiopancreatography Market by Product Type (Endoscopes, Endotherapy Devices, Imaging Systems, Energy Devices, And Others), Application (Biliary Sphincterotomy, Biliary Dilatation, Biliary Stenting, Pancreatic Sphincterotomy, Pancreatic Duct Dilatation, And Pancreatic Duct Stenting), and End User (Hospitals & Clinics, Ambulatory Surgery Centers, And Others): Global Opportunity Analysis and Industry Forecast, 2019-2027)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。